Cannabinoids

Cardiovascular Pharmacology of Cannabinoids 607 SR141716-sensitive CB receptors on vascular smooth muscle cells, which it would ...

608 P. Pacher et al. dependent manner, the anandamide response was unaffected by gap junction inhibitors (Mukhopadhyay et al. 20 ...

Cardiovascular Pharmacology of Cannabinoids 609 Abn-cbdisasyntheticanalogofthebehaviorallyinactiveplant-derivedcannabi- noid, ca ...

610 P. Pacher et al. (Mukhopadhyay et al. 2002). These findings are in general good agreement with the earlier findings in the r ...

Cardiovascular Pharmacology of Cannabinoids 611 indicate that O-1918 inhibits the mesenteric vasorelaxant effect of two putative ...

612 P. Pacher et al. current under Ca2+-clamped conditions, indicating that its action is not due to modulation of [Ca2+]i.Theef ...

Cardiovascular Pharmacology of Cannabinoids 613 that anandamide, R-methanandamide, and HU-210 dose-dependently decrease contract ...

614 P. Pacher et al. activation of TRPV1 receptors in sensory nerves and the subsequent release of the potent vasodilator peptid ...

Cardiovascular Pharmacology of Cannabinoids 615 and is unaffected by the CB 1 antagonist SR141716 in rats (Varga et al. 1995). ...

616 P. Pacher et al. al. 2004a; Wang et al. 2001; Godlewski et al. 2004), and cardiogenic shock (Wagner et al. 2001a, 2003). The ...

Cardiovascular Pharmacology of Cannabinoids 617 5.2 Role of the Endocannabinergic System in Myocardial Reperfusion Damage Intere ...

618 P. Pacher et al. Following the introduction of selective CB receptor antagonists in the mid 1990s, the finding that treatmen ...

Cardiovascular Pharmacology of Cannabinoids 619 References Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, Makriya ...

620 P. Pacher et al. Carruba MO, Bondiolotti G, Picotti GB, Catteruccia N, Da Prada M (1987) Effects of di- ethyl ether, halotha ...

Cardiovascular Pharmacology of Cannabinoids 621 Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR (1999) Cannabinoid C ...

622 P. Pacher et al. Kosersky DS (1978) Antihypertensive effects of delta9-tetrahydrocannabinol. Arch Int Phar- macodyn Ther 233 ...

Cardiovascular Pharmacology of Cannabinoids 623 Matsuda LA, Lolait SJ, Brownstein MJ, Young CA, Bonner TI (1990) Structure of a ...

624 P. Pacher et al. Randall MD, Alexander SP, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCul- loch AI, Kendall DA (199 ...

Cardiovascular Pharmacology of Cannabinoids 625 Vollmer RR, Cavero I, Ertel RJ, Solomon TA, Buckley JP (1974) Role of the centra ...

HEP (2005) 168:627–642 ©cSpringer-Verlag 2005 Effects on Cell Viability M. Guzmán Department of Biochemistry and Molecular Biolo ...